Companies /Healthcare

Biomarin Pharmaceutical Inc

NASDAQ: BMRN Biotechnology
$63.94
▼ $1.14 (−1.75%) today
Markets closed · 9:05am ET

BMRN Coverage

Page 11
9:06am ET
Health and Healthcare

BioMarin Drug Meets Endpoint and Will Seek FDA Approval

via Wikimedia CommonsBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is surging on news that a drug met its primary endpoint and that it will seek approval in early 2013. The company’s Phase III study of GALNS is…

Jon C. Ogg